Starbucks: Analysts Expect Q4 Earnings of $0.99 Per Share

Starbucks (NASDAQ: SBUX) will be reporting its fourth quarter financial results today after the markets close. Analysts have a consensus $129.25 12-month price target on the company, via a total of 37 analysts, with 12 analysts having strong buy ratings. 10 analysts meanwhile have buy ratings, 14 analysts have a hold rating and a single analyst has a sell rating on the company. The street high comes from Kalinowski Equity Research with a $148 price target, and the lowest target sits at $95.

26 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 26 analysts is $8.21 billion; this number has been revised upwards from $8.07 billion at the start of April. The highest revenue estimate is $8.45 billion, while the lowest is $7.92 billion.

Onto EBITDA estimates, there are currently 18 analysts who have fourth-quarter EBITDA estimates. The mean is currently $1.93 billion, with this number having been revised upwards from $1.9 billion at the start of April. The street high estimate currently sits at $2.05 billion in EBITDA and the lowest is $1.85 billion.

Analysts estimate that quarterly earnings per share will come in at $0.99, with this number being revised upwards from $0.96 at the start of April. Street high is $1.05 and the lowest estimate is $10.93 per share for the quarter.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Why Industrial Demand Is Changing the Silver Market | David Morgan

Gold and Silver Delivery Is Exposing the Paper Market | Andy Schectman

Recommended

Nations Royalty Names Derrick Pattenden As President And CEO

First Phosphate Receives US$530,000 Pre-Payment Under Offtake Agreement

Related News

Equinox Gold: BMO Lifts Target To $14.50

Earlier this week, Equinox Gold Corp. (TSX: EQX) reported its first quarter financial results for...

Friday, May 6, 2022, 11:56:01 AM

Organigram: Consensus Price Target Falls To $3.55

On November 23rd, Organigram Holdings (TSX: OGI) announced its fourth quarter fiscal 2021 results. The...

Sunday, November 28, 2021, 01:18:00 PM

HEXO: Canaccord Lowers Price Target Following Redecan Transaction Announcement

On May 28th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced yet another acquisition. The company...

Tuesday, June 1, 2021, 11:51:00 AM

Cresco Labs: Consensus First Quarter 2021 Estimates

Cresco Labs (CSE: CL) announced that they will be reporting their first quarter financials before...

Tuesday, May 25, 2021, 11:51:00 AM

Organigram: Mixed Commentary From Analysts Following Q1 2021 Results

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) yesterday morning reported its first-quarter 2021 financial results for...

Wednesday, January 13, 2021, 11:55:00 AM